133 related articles for article (PubMed ID: 8097804)
1. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk.
Jha PK; Beral V; Peto J; Hack S; Hermon C; Deacon J; Mant D; Chilvers C; Vessey MP; Pike MC
Lancet; 1993 May; 341(8853):1116-8. PubMed ID: 8097804
[TBL] [Abstract][Full Text] [Related]
2. A population-based seroepidemiological study of cervical cancer.
Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
[TBL] [Abstract][Full Text] [Related]
3. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras.
Ferrera A; Baay MF; Herbrink P; Figueroa M; Velema JP; Melchers WJ
Int J Cancer; 1997 Dec; 73(6):781-5. PubMed ID: 9399651
[TBL] [Abstract][Full Text] [Related]
4. Genital Chlamydia trachomatis infections in patients with cervical atypia.
Paavonen J; Vesterinen E; Meyer B; Saikku P; Suni J; Purola E; Saksela E
Obstet Gynecol; 1979 Sep; 54(3):289-91. PubMed ID: 224353
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer.
Hildesheim A; Mann V; Brinton LA; Szklo M; Reeves WC; Rawls WE
Int J Cancer; 1991 Sep; 49(3):335-40. PubMed ID: 1655658
[TBL] [Abstract][Full Text] [Related]
6. Sexually transmitted infections and cervical atypia.
Schachter J
Sex Transm Dis; 1981; 8(4 suppl):353-6. PubMed ID: 6277023
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
[TBL] [Abstract][Full Text] [Related]
8. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma.
Lehtinen M; Leminen A; Kuoppala T; Tiikkainen M; Lehtinen T; Lehtovirta P; Punnonen R; Vesterinen E; Paavonen J
J Med Virol; 1992 Jul; 37(3):180-6. PubMed ID: 1331306
[TBL] [Abstract][Full Text] [Related]
9. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor.
Simonetti AC; Melo JH; de Souza PR; Bruneska D; de Lima Filho JL
Microbes Infect; 2009 Apr; 11(4):435-42. PubMed ID: 19397882
[TBL] [Abstract][Full Text] [Related]
10. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
Madeleine MM; Anttila T; Schwartz SM; Saikku P; Leinonen M; Carter JJ; Wurscher M; Johnson LG; Galloway DA; Daling JR
Int J Cancer; 2007 Feb; 120(3):650-5. PubMed ID: 17096345
[TBL] [Abstract][Full Text] [Related]
11. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
12. Chlamydia trachomatis and cervical neoplasia.
Schachter J; Hill EC; King EB; Heilbron DC; Ray RM; Margolis AJ; Greenwood SA
JAMA; 1982 Nov; 248(17):2134-8. PubMed ID: 6288978
[TBL] [Abstract][Full Text] [Related]
13. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women.
Finan RR; Musharrafieh U; Almawi WY
Clin Microbiol Infect; 2006 Sep; 12(9):927-30. PubMed ID: 16882302
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 2 and human papillomavirus type 16 in cervicitis, dysplasia and invasive cervical carcinoma.
Prakash SS; Reeves WC; Sisson GR; Brenes M; Godoy J; Bacchetti S; de Britton RC; Rawls WE
Int J Cancer; 1985 Jan; 35(1):51-7. PubMed ID: 2981783
[TBL] [Abstract][Full Text] [Related]
15. Human papillomaviruses and other influences on survival from cervical cancer in Panama.
DeBritton RC; Hildesheim A; De Lao SL; Brinton LA; Sathya P; Reeves WC
Obstet Gynecol; 1993 Jan; 81(1):19-24. PubMed ID: 8380103
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.
Hrbacek J; Urban M; Hamsikova E; Tachezy R; Eis V; Brabec M; Heracek J
BMC Cancer; 2011 Feb; 11():53. PubMed ID: 21291519
[TBL] [Abstract][Full Text] [Related]
18. Association of human papillomavirus and Chlamydia trachomatis with intraepithelial alterations in cervix samples.
Wohlmeister D; Vianna DR; Helfer VE; Gimenes F; Consolaro ME; Barcellos RB; Rossetti ML; Calil LN; Buffon A; Pilger DA
Mem Inst Oswaldo Cruz; 2016 Feb; 111(2):106-13. PubMed ID: 26841046
[TBL] [Abstract][Full Text] [Related]
19. [Etiological role of the herpes simplex virus in causing cervical cancer].
Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
[TBL] [Abstract][Full Text] [Related]
20. Serological assays for the detection of HPV antibodies.
Galloway DA
IARC Sci Publ; 1992; (119):147-61. PubMed ID: 1330907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
